The Hydration Pharmaceuticals Co (ASX:HPC) 3-Year ROIIC % : -262.57% (As of Dec. 2025)
What is The Hydration Pharmaceuticals Co 3-Year ROIIC %?
The Hydration Pharmaceuticals CoASX:HPC 3-Year ROIIC % is -262.57 as of Dec. 2025. The stock has 3 warning signs investors should review. Among 293 Retail - Defensive companies, The Hydration Pharmaceuticals Co ranks worse than 97.95% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
The Hydration Pharmaceuticals Co's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was -262.57%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
ASX:HPC's 3-Year ROIIC % is ranked worse than 97.95% of 293
companies
in the Retail - Defensive industry
Industry Median: 5.95
vs ASX:HPC: -262.57
The Hydration Pharmaceuticals Co (ASX:HPC) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
The Hydration Pharmaceuticals Co 3-Year ROIIC % Related Terms
The Hydration Pharmaceuticals Co 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Hydration Pharmaceuticals Co 3-Year ROIIC % Chart
ASX:HPC vs SYY, USFD, PFGC: 3-Year ROIIC % Comparison
For the Food Distribution subindustry, The Hydration Pharmaceuticals Co's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Hydration Pharmaceuticals Co 3-Year ROIIC % vs Retail - Defensive Industry
For the Retail - Defensive industry and Consumer Defensive sector, The Hydration Pharmaceuticals Co's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where The Hydration Pharmaceuticals Co's 3-Year ROIIC % falls into.
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -4.735 (Dec. 2025) - -15.86 (Dec. 2022) )
/
( 0.767 (Dec. 2025) - 5.004 (Dec. 2022) )
=
11.125
/
-4.237
=
-262.57%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
The Hydration Pharmaceuticals Co (ASX:HPC) has a 3-Year ROIIC % of -262.57 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on The Hydration Pharmaceuticals Co and its competitors. According to the industry distribution chart, The Hydration Pharmaceuticals Co ranks #287 out of 293 companies in the Retail - Defensive industry, placing it in the top 98%.
Is The Hydration Pharmaceuticals Co's 3-Year ROIIC % too high?
The Hydration Pharmaceuticals Co's current 3-Year ROIIC % is -262.57. Based on the distribution chart, The Hydration Pharmaceuticals Co ranks #287 out of 293 companies in the Retail - Defensive industry, which is in the bottom quartile relative to peers.
How does The Hydration Pharmaceuticals Co's 3-Year ROIIC % compare to SYY and USFD?
According to the Retail - Defensive industry distribution chart, The Hydration Pharmaceuticals Co ranks #287 out of 293 companies for 3-Year ROIIC %. This places The Hydration Pharmaceuticals Co in the lower half of its industry. The industry median 3-Year ROIIC % is 5.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Retail - Defensive company?
The median 3-Year ROIIC % among Retail - Defensive companies is 5.95, based on 293 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on The Hydration Pharmaceuticals Co and its competitors. For the Retail - Defensive industry, the median 3-Year ROIIC % is 5.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Hydration Pharmaceuticals Co's current 3-Year ROIIC % is -262.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Hydration Pharmaceuticals Co stock overvalued right now?
The Hydration Pharmaceuticals Co (ASX:HPC) has a current 3-Year ROIIC % of -262.57. The current 3-Year ROIIC % is -262.57. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For The Hydration Pharmaceuticals Co (ASX:HPC), the current 3-Year ROIIC % is -262.57 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
The Hydration Pharmaceuticals Co Business Description
The Hydration Pharmaceuticals Co Ltd is a consumer products company that markets and sells a range of liquid, tablet and powder Healthy Hydration Solutions products into the USA market, under the Hydralyte brand. Hydralyte collates and translates consumer insights and needs into developing and delivering quality hydration products to market. The Company's business model is an asset light, flexible production model that allows it to outsource manufacturing and packaging to appropriate suppliers.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:HPC has been successfully added to your 